The aim of this guide is to provide its readers with a pragmatic overview of the law and practice of pharmaceutical advertising law across a variety of jurisdictions.
Each chapter of this guide provides information about the current issues affecting pharmaceutical advertising in a particular country and addresses topics such as self-regulation, press releases, gifts, samples, grants or donations, anti-bribery rules, regulatory authorities and courts, as well as insight and opinion on the most common issues in their respective country.
The Q&A template for each chapter has been provided by Sally Shorthose of Bird & Bird.
The aim of this guide is to provide its readers with a pragmatic overview of the law and practice of pharmaceutical advertising law across a variety of jurisdictions.
Each chapter of this guide provides information about the current issues affecting pharmaceutical advertising in a particular country and addresses topics such as self-regulation, press releases, gifts, samples, grants or donations, anti-bribery rules, regulatory authorities and courts, as well as insight and opinion on the most common issues in their respective country.
The Q&A template for each chapter has been provided by Sally Shorthose of Bird & Bird.
Hot Topic: Artificial Intelligence in Drug Development
Introduction The pharmaceutical and biotechnology industry is experiencing a technological revolution in drug discovery and development with the promise of artificial intelligence (“AI”). AI has the potential to make the drug discovery and development process more efficient, faster, more accurate and, importantly, AI may enable researchers and companies to discover and deliver novel medicines for …
Continue reading “Artificial Intelligence in Drug Development”